• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献 >>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

血必净与低分子肝素对严重脓毒症患者凝血功能及预后的影响

The influence of Xuebijing injection and low molecular weight heparin on coagulation function and prognosis in patients with severe sepsis

摘要:

目的 比较血必净与低分子肝素(low molecular weight heparin,LMWH)对严重脓毒症患者凝血功能及疾病预后的影响,以指导脓毒症的治疗.方法 将89例经随访取得有效数据的严重脓毒症患者随机(随机数字法)分为3组,血必净组(A组)、LMWH组(B组)和常规组(C组).C组给予常规治疗,A组及B组在常规治疗的基础上分别加用血必净注射液和LMWH联合治疗.3组分别于治疗前及治疗后7 d检测凝血指标,记录APACHE Ⅱ评分,随访统计住院天数及28 d病死率.统计分析采用成组t检验、方差分析、q检验、x2检验和秩和检验,以P<0.05为差异具有统计学意义.结果 ①治疗后与治疗前组内比较,A组各凝血指标均有明显改善(P<0.01),其余2组有部分凝血指标改善(P<0.05或P<0.01);治疗后经组间比较,A组各凝血指标较其他2组改善明显(P<0.05),B组与C组比较,只有部分指标改善(P<0.05).②治疗后与治疗前比较,A组及B组APACHEⅡ评分明显下降(P<0.05);治疗后经组间比较,A组与B组APACHEⅡ评分差异无统计学意义(P>0.05),二者分别与C组比较明显下降(P<0.05).③3组住院天数比较差异无统计学意义(P>0.05).④3组28 d病死率比较,A组及B组较C组28 d病死率降低,差异具有统计学意义(均P<0.05).结论 血必净可明显改善严重脓毒症患者的凝血功能,低分子肝素只能改善部分凝血指标;二者均可降低病死率、改善预后.

更多
abstracts:

Objective To compare between the impact of Xuebijing injectio (a Chinese herbal medicine preparation) and that of low molecular weight heparin (LMWH) on coagulation function and prognosis in patients with severe sepsis, so as to guide the treatment of sepsis. Method A total of 89 patients with severe sepsis were randomly(random number) divided into 3 groups, namely Xuebijing group (group A),LMWH group (group B) and routine group (group C). The patients of group C received a series of remedies according to the guideline for severe sepsis. The patients of group A were treated with Xuebijing injectio in addition to routine treatment. The patients of group B were treated with LMWH along with routine treatment.Data of blood coagulation function tests and APACHE Ⅱ score of patients in three groups before and after treatment were analyzed respectively. The 28-day mortality and length of hospital stay were compared among three groups. All data were analyzed by using t-test, Analysis of Variance, q-test, x2-test and rank sum treatment, all markers of the blood coagulation function tests in group A improved significantly after treatment (P<0.01), while only some markers of the blood coagulation function tests improved in the other two groups ( P < 0. 05 or P < 0. 01 ); After treatment, the blood coagulation function in group A improved significantly more than that in other two groups ( P < 0.05 ), while there were some markers of the blood coagulawith the data before treatment, the APACHE Ⅱ score in group A and group B decreased after treatment (P<0.05). After treatment, the APACHE Ⅱ score of group A and group B decreased significantly more than that of group C ( P < 0.05). But there was no significant difference between group A and group B ( P >Xuebijing obviously improves the blood coagulation function in patients with severe sepsis, while LMWH only improves some markers of the coagulation function tests. Both Xuebijing and LMWH reduce mortality and improve prognosis of patients with sepsis.

More
  • 浏览:422
  • 下载:348

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷